Inventor
DANIEL M. CANAFAX
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes52%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations48%
PatentTitleYear
12,396,956Modified release compositions of a gamma-hydroxybutyric acid derivative202512,396,966Pharmaceutical compositions and oral dosage forms of ketamine derivatives202512,337,066Controlled release granulations of water-soluble active pharmaceutical ingredients202511,944,597Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative202411,925,710Modified release compositions of a GAMMA-hydroxybutyric acid derivative202411,896,573Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative202411,690,811Pharmaceutical compositions and oral dosage forms of ketamine derivatives202311,510,892Pharmacokinetics of combined release formulations of a g-hydroxybutyric acid derivative202211,395,801Modified release compositions of a gamma-hydroxybutyric acid derivative202211,357,734Pharmaceutical granulations of water-soluble active pharmaceutical ingredients202211,304,906Controlled release granulations of water-soluble active pharmaceutical ingredients2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to XWPHARMA LTD (11)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XWPHARMA LTD | 11 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2022–2025 |